Funding boost for green catalyst tech

By Nick Taylor

- Last updated on GMT

Related tags: Hydrogenation, Catalysis

Research into the development of cheaper, less environmentally damaging catalysts should be furthered by a grant awarded by the ACS Green Chemistry Institute.

The grant has been given to Yale University chemistry professor Robert Crabtree for use in his research into developing catalysts derived from iron, copper and cobalt.

By using these metals instead of traditional materials, such as platinum, iridium and chloride, the American Chemical Society (ACS) believes the cost and environmental harm of drug manufacture could be reduced.

Andrew Wells, senior principal scientist, AstraZeneca Global Process R&D, and Peter Dunn, Pfizer Green Chemistry Lead, said in a joint statement: “Increasing the efficiency of synthetic routes using improved catalytic techniques and avoiding potentially mutagenic alkylating agents are high priorities for the pharmaceutical industry, and this research project promises to extend and improve the methodology that is available to the chemistry community​.”

Crabtree has received $160,000 that he will use over the next two years to further his research into catalysts. His work into green catalytic reactions has includes the use of transfer hydrogenation with aldehydes, ketones, alkenes and imines.

In addition his research group has worked on green synthesis of amides. This was achieved by forming an oxaziridine and catalytically rearranging it to produce an amide.

Crabtree has focused his research on the development of chemistry that could have practical applications and be relatively easily incorporated into a company’ production processes.

The grant programme began in 2007 and since then has provided $650,000 for research into creating greener pathways to drug production.

Related news

Show more

Related products

show more

Strategies to Achieve Successful Approval & Launch

Strategies to Achieve Successful Approval & Launch

Catalent Pharma Solutions | 03-Sep-2020 | Data Sheet

There are several key considerations to how companies should approach commercial-scale manufacturing that may aid the success of their biologic’s launch...

Single-Pass Tangential Flow Filtration

Single-Pass Tangential Flow Filtration

BioContinuum™ Platform - MilliporeSigma | 01-Aug-2020 | Application Note

Tangential flow filtration (TFF) is widely used in the biopharmaceutical industry for downstream processing applications. Typical TFF steps concentrate...

Follow us


View more